Zdrowie i gospodarka · 01/04/2024

FDA Finalizes Guidance for Electronic Submission of IND Safety Reports

The Food and Drug Administration (FDA) has released a final guidance outlining the electronic format requirements for submitting investigational new drug application (IND) safety reports, which will become effective 24 months after publication on April 1, 2026.